NewMediaWire
Paid press release content from NewMediaWire. The StreetInsider.com news staff was not involved in its creation.
More NewMediaWire
View Older Stories View Newer Stories-
Golden Matrix Group Reports $150M Preliminary FY 2024 Consolidated Revenue Guidance
-
Mobile-health Network Solutions Issues 2024 Year-end Letter to Shareholders
-
Aemetis Biogas Receives $11 Million From Sale of IRA Investment Tax Credits
-
SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter 2024 (Ended December 31, 2024)
-
SANUWAVE Health Appoints Industry Veteran Timothy Wern as Executive Vice President of Sales
-
Shrihari Allangala Joins Blackwell 3D Board, Set to Lead Growth and Strategic Expansion of Consulting Division
-
The Pennsylvania Dental Association Expands Endorsement to Include iCoreRx Cloud ePrescribing
-
GeoVax to Review 2024 Progress at the Emerging Growth Conference on January 16, 2025
-
Metavesco's Epic Labor Books Q4 2024 Revenue of $472,299
-
Intelligent Protection Management Corp. Appoints Barry Sloane and Sidney Rabsatt to Board of Directors
-
Fortran Corporation Completes Acquisition
-
ABVC BioPharma and ForSeeCon: An Update on Alliance's Ophthalmology-Related Products
-
Intelligent Protection Management Corp. Commences Trading on The Nasdaq Capital Market Under the Ticker Symbol IPM
-
Aemetis Biogas Commissioned Three New Dairy Digesters in December 2024, Increasing Expected RNG Production Capacity by 80% to 550,000 MMBtu Per Year for 2025
-
GlobeTopper Achieves Record $4.3M in December 2024 Revenue
-
CGRA Signs Binding Term Sheet to Merge With American Infrastructure Corporation, a Subsidiary of Nasdaq-listed American Resources Corporation (Nasdaq: AREC)
-
GeoVax to Review 2024 Progress at Biotech Showcase During J.P. Morgan Healthcare Week 2025
-
Aclarion Announces Pricing of Registered Direct Offering of Common Stock Priced at the Market
-
Mobile-health Network Solutions to Deliver a Live Presentation at the Skyline Signature Series on Tuesday, January 14th at 11 AM ET
-
ABVC BioPharma Secures an Additional Patent for ADHD Treatment, in Addition to the Granted U.S. and Australian Patents, Moving Forward to the Global Patent Map of $32.14 Billion Potential Market
-
Golden Matrix Group Subsidiary Meridianbet Secures Online Betting License in Brazil
-
Accredited Solutions Issues Year-End Shareholder Letter
-
Blackwell 3D Welcomes Experienced M&A Specialist to Its Board of Directors
-
Endexx Corporation (OTC: EDXC) Announces Significant Sustainable Growth and Strong Financial Improvements in Year-End Shareholder Update
-
Innovative Designs Inc. Reports Record Sales Results to Shareholders
-
Metavesco's Epic Labor Books November Revenue of $185,072, Plans Major Expansion in Q1 2025
-
iMD Companies and Its Subsidiary, Riize LLC, Announce Adding NAD+ to Its Rapid Dissolving Film Strip Technology
-
VPR Brands Expands Legal Success With New Settlement Agreement to Strengthen Industry Leadership
-
The Crypto Company Highlights Blockchain Training Alliance's Successes and Momentum for 2025
-
Mobile-health Network Solutions Announces Closing of City Gate Clinic, Charts Path Forward in 2025
-
Golden Matrix Group Enters the U.S. Sweepstakes Market Through Partnership With Moozi
-
Aclarion Announces Closing of $14.4 Million Public Offering of Common Stock and Warrants
-
ABVC BioPharma and AiBtl BioPharma's Worldwide Business Development Team Participate in the 43rd Annual J.P. Morgan Healthcare Conference
-
Fortun's Year-End Earnings Signal Continued Exponential Growth for 2025
-
GeoVax Announces Major Gedeptin Milestone With Plans of Phase 2 Trial
-
ABVC BioPharma's ADHD and MDD Drug Polygala Tenuifolia a Natural Wonder With Potential of Transforming Mental Health Treatment of More Than 30 Billion Market
-
AiBtl BioPharma Strengthens Partnership With ABVC BioPharma, Paying $150,000 in Licensing Fees
-
ABVC BioPharma, Inc. Granted Additional 180-Day Grace Period to Regain Compliance With Nasdaq Bid Price Requirement
-
GeoVax Achieves Significant Progress in Next-Generation COVID-19 Vaccine Development Throughout 2024
-
SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter 2024 (Ended December 31, 2024)
-
ZenaTech Announces Participation at Two January Investor Conferences to Provide a Business Update on Its AI Drone, US Defense and Quantum Computing Initiatives
-
Paltalk, Inc. Completes Acquisition of Newtek Technology Solutions, Inc.
-
GeoVax to Review 2024 Progress at the Emerging Growth Conference on January 16, 2025
-
Metavesco's Epic Labor Books Q4 2024 Revenue of $472,299
-
Intelligent Protection Management Corp. Appoints Barry Sloane and Sidney Rabsatt to Board of Directors
-
ABVC BioPharma and ForSeeCon: An Update on Alliance's Ophthalmology-Related Products
-
CGRA Signs Binding Term Sheet to Merge With American Infrastructure Corporation, a Subsidiary of Nasdaq-listed American Resources Corporation (Nasdaq: AREC)
-
GeoVax to Review 2024 Progress at Biotech Showcase During J.P. Morgan Healthcare Week 2025
-
Aclarion Announces Pricing of Registered Direct Offering of Common Stock Priced at the Market
-
Paltalk, Inc. Completes Acquisition of Newtek Technology Solutions, Inc.
